Statement of Principles
concerning
 
MICROSCOPIC POLYANGIITIS
No. 13 of 2011
 
for the purposes of the
 
Veterans’ Entitlements Act 1986
and
Military Rehabilitation and Compensation Act 2004
           
Title
1.         This Instrument may be cited as Statement of Principles concerning microscopic polyangiitis No. 13 of 2011.
 
Determination
2.         This Statement of Principles is determined by the Repatriation Medical Authority under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the VEA).
 
Kind of injury, disease or death
3.         (a)        This Statement of Principles is about microscopic polyangiitis and death from microscopic polyangiitis.
(b)               For the purposes of this Statement of Principles, "microscopic polyangiitis" means a necrotising vasculitis of capillaries, venules or arterioles that typically involves the lungs, kidneys and peripheral nervous system.
(c)              Microscopic polyangiitis attracts ICD-10-AM code M31.7.
(d)              In the application of this Statement of Principles, the definition of "microscopic polyangiitis" is that given at paragraph 3(b) above.
 
Basis for determining the factors
4.         The Repatriation Medical Authority is of the view that there is sound medical-scientific evidence that indicates that microscopic polyangiitis and death from microscopic polyangiitis can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the Military Rehabilitation and Compensation Act 2004 (the MRCA).
 
Factors that must be related to service
5.         Subject to clause 7, at least one of the factors set out in clause 6 must be related to the relevant service rendered by the person.
 
Factors
6.         The factor that must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting microscopic polyangiitis or death from microscopic polyangiitis with the circumstances of a person’s relevant service is:
 
(a)                being treated with propylthiouracil or hydralazine at the time of the clinical onset of microscopic polyangiitis; or
 
(b)               inhaling respirable crystalline silica dust, at the time material containing crystalline silica was being:
(i)         produced;
(ii)        excavated;
(iii)       drilled, cut or ground; or
(iv)              used in construction, manufacturing, cleaning or blasting,
for a cumulative period of at least 2500 hours before the clinical onset of microscopic polyangiitis; or
 
(c)                being treated with propylthiouracil or hydralazine at the time of the clinical worsening of microscopic polyangiitis; or
 
(d)               inhaling respirable crystalline silica dust, at the time material containing crystalline silica was being:
(i)         produced;
(ii)        excavated;
(iii)       drilled, cut or ground; or
(iv)              used in construction, manufacturing, cleaning or blasting,
for a cumulative period of at least 2500 hours before the clinical worsening of microscopic polyangiitis; or
 
(e)                inability to obtain appropriate clinical management for microscopic polyangiitis.
 
Factors that apply only to material contribution or aggravation
7.         Paragraphs 6(c) to 6(e) apply only to material contribution to, or aggravation of, microscopic polyangiitis where the person’s microscopic polyangiitis was suffered or contracted before or during (but not arising out of) the person’s relevant service.
 
Inclusion of Statements of Principles
8.         In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.
 
Other definitions
9.         For the purposes of this Statement of Principles:
 
"death from microscopic polyangiitis" in relation to a person includes death from a terminal event or condition that was contributed to by the person’s microscopic polyangiitis;
 
"ICD-10-AM code" means a number assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM), Seventh Edition, effective date of 1 July 2010, copyrighted by the National Centre for Classification in Health, Sydney, NSW, and having ISBN 978 1 74210 154 5;
 
"relevant service" means:
(a)                operational service under the VEA;
(b)               peacekeeping service under the VEA;
(c)                hazardous service under the VEA;
(d)               warlike service under the MRCA; or
(e)                non-warlike service under the MRCA;
 
"terminal event" means the proximate or ultimate cause of death and includes:
(a)                pneumonia;
(b)               respiratory failure;
(c)                cardiac arrest;
(d)                circulatory failure; or
(e)                cessation of brain function.
 
Date of effect
10.       This Instrument takes effect from 5 January 2011.
 
Dated this   fourteenth   day of   December   2010
 
 
The Common Seal of the                      )
Repatriation Medical Authority  )
was affixed to this instrument                 )
in the presence of:                                 )
 
KEN DONALD
CHAIRPERSON